251 related articles for article (PubMed ID: 32525789)
1. The Role of Molecular Imaging in the Assessment of Cardiac Amyloidosis: State-of-the-Art.
Popescu C; Burger IA
Curr Radiopharm; 2021; 14(3):228-241. PubMed ID: 32525789
[TBL] [Abstract][Full Text] [Related]
2. Molecular Imaging of Cardiac Amyloidosis.
Pelletier-Galarneau M; Abikhzer G; Giraldeau G; Harel F
Curr Cardiol Rep; 2019 Feb; 21(3):12. PubMed ID: 30815746
[TBL] [Abstract][Full Text] [Related]
3. Targeted Nuclear Imaging Probes for Cardiac Amyloidosis.
Bravo PE; Dorbala S
Curr Cardiol Rep; 2017 Jul; 19(7):59. PubMed ID: 28508350
[TBL] [Abstract][Full Text] [Related]
4. It Takes a Village: Multimodality Imaging of Cardiac Amyloidosis.
Saad JM; Ahmed AI; Anugula D; Han Y; Alfawara MS; Al-Mallah MH
Methodist Debakey Cardiovasc J; 2022; 18(2):47-58. PubMed ID: 35414854
[TBL] [Abstract][Full Text] [Related]
5. Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease?
Cuddy SAM; Bravo PE; Falk RH; El-Sady S; Kijewski MF; Park MA; Ruberg FL; Sanchorawala V; Landau H; Yee AJ; Bianchi G; Di Carli MF; Cheng SC; Jerosch-Herold M; Kwong RY; Liao R; Dorbala S
JACC Cardiovasc Imaging; 2020 Jun; 13(6):1325-1336. PubMed ID: 32417333
[TBL] [Abstract][Full Text] [Related]
6. Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques.
Aljaroudi WA; Desai MY; Tang WH; Phelan D; Cerqueira MD; Jaber WA
J Nucl Cardiol; 2014 Apr; 21(2):271-83. PubMed ID: 24347127
[TBL] [Abstract][Full Text] [Related]
7. Nuclear imaging modalities for cardiac amyloidosis.
Bokhari S; Shahzad R; Castaño A; Maurer MS
J Nucl Cardiol; 2014 Feb; 21(1):175-84. PubMed ID: 24162886
[TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation of Tc-99m p5+14 peptide for SPECT detection of cardiac amyloidosis.
Kennel SJ; Jackson JW; Stuckey A; Richey T; Foster JS; Wall JS
PLoS One; 2024; 19(4):e0301756. PubMed ID: 38578730
[TBL] [Abstract][Full Text] [Related]
9. Cardiac Amyloid Imaging with 18F-Florbetaben PET: A Pilot Study.
Law WP; Wang WY; Moore PT; Mollee PN; Ng AC
J Nucl Med; 2016 Nov; 57(11):1733-1739. PubMed ID: 27307344
[TBL] [Abstract][Full Text] [Related]
10. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.
Bennani Smires Y; Victor G; Ribes D; Berry M; Cognet T; Méjean S; Huart A; Roussel M; Petermann A; Roncalli J; Carrié D; Rousseau H; Berry I; Chauveau D; Galinier M; Lairez O
Int J Cardiovasc Imaging; 2016 Sep; 32(9):1403-1413. PubMed ID: 27240600
[TBL] [Abstract][Full Text] [Related]
11. [Bone seeking tracers' scintigraphy for the diagnosis of transthyretin cardiac amyloidosis].
Daquarti GJ; Meretta A; Corneli M; Costabel JP; Diez M; Masoli OH
Medicina (B Aires); 2018; 78(6):395-398. PubMed ID: 30504105
[TBL] [Abstract][Full Text] [Related]
12. Imaging in systemic amyloidosis.
Sachchithanantham S; Wechalekar AD
Br Med Bull; 2013; 107():41-56. PubMed ID: 23896486
[TBL] [Abstract][Full Text] [Related]
13. Detection of cardiac amyloidosis with
Kircher M; Ihne S; Brumberg J; Morbach C; Knop S; Kortüm KM; Störk S; Buck AK; Reiter T; Bauer WR; Lapa C
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1407-1416. PubMed ID: 30798427
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers.
Kyriakou P; Mouselimis D; Tsarouchas A; Rigopoulos A; Bakogiannis C; Noutsias M; Vassilikos V
BMC Cardiovasc Disord; 2018 Dec; 18(1):221. PubMed ID: 30509186
[TBL] [Abstract][Full Text] [Related]
15. Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction.
Chen W; Ton VK; Dilsizian V
Curr Cardiol Rep; 2018 Mar; 20(4):23. PubMed ID: 29520480
[TBL] [Abstract][Full Text] [Related]
16. Advanced Nuclear Medicine and Molecular Imaging in the Diagnosis of Cardiomyopathy.
Yang M; Arsanjani R; Roarke MC
AJR Am J Roentgenol; 2020 Nov; 215(5):1208-1217. PubMed ID: 32901569
[No Abstract] [Full Text] [Related]
17. Molecular Imaging of Systemic and Cardiac Amyloidosis: Recent Advances and Focus on the Future.
Dorbala S; Kijewski MF
J Nucl Med; 2023 Nov; 64(Suppl 2):20S-28S. PubMed ID: 37918844
[TBL] [Abstract][Full Text] [Related]
18. [Cardiac scintigraphy-centered diagnostic process in transthyretin cardiac amyloidosis].
Ak Sivrikoz I; Çavuşoğlu Y
Turk Kardiyol Dern Ars; 2020 Jul; 48(5):514-521. PubMed ID: 32633270
[TBL] [Abstract][Full Text] [Related]
19. Cardiac Amyloidosis: Updates in Imaging.
Chacko L; Martone R; Cappelli F; Fontana M
Curr Cardiol Rep; 2019 Aug; 21(9):108. PubMed ID: 31375984
[TBL] [Abstract][Full Text] [Related]
20. Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis: JACC Review Topic of the Week.
Hanna M; Ruberg FL; Maurer MS; Dispenzieri A; Dorbala S; Falk RH; Hoffman J; Jaber W; Soman P; Witteles RM; Grogan M
J Am Coll Cardiol; 2020 Jun; 75(22):2851-2862. PubMed ID: 32498813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
